WCLC 2023

WCLC 2023
September 09-12, 2023

World Conference on Lung Cancer 2023.

Explore more information for Gilead Oncology therapies
Results (3)

Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study

EDGE-Lung: A Phase 2 Open-Label Platform Study to Evaluate Immunotherapy-Based Combinations in Patients with Metastatic NSCLC

STAR-121: Phase 3 Study of Domvanalimab and Zimberelimab plus Chemo vs Pembrolizumab plus Chemo in 1L mNSCLC with No Actionable Gene Alterations